MedPath

University of Nairobi

University of Nairobi logo
🇰🇪Kenya
Ownership
Private
Established
1956-01-01
Employees
5K
Market Cap
-
Website
http://www.uonbi.ac.ke

Intravenous Enhancin[Co-amoxiclav] Versus Postoperative Enhancin in Prevention of Postadenotonsillectomy Morbidity.

Not Applicable
Completed
Conditions
Adenotonsillar Hypertrophy,Under 12 Years.
Interventions
Drug: Enhancin
First Posted Date
2010-12-29
Last Posted Date
2010-12-29
Lead Sponsor
University of Nairobi
Target Recruit Count
126
Registration Number
NCT01267942
Locations
🇰🇪

Kenyatta National Hospital., Nairobi., Kenya

© Copyright 2025. All Rights Reserved by MedPath